Muzi, M.; O’Sullivan, F.; Perk, T.G.; Muzi, J.P.; Mankoff, D.A.; Jeraj, R.; Duan, F.; Yu, E.Y.
Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687. Tomography 2021, 7, 139-153.
https://doi.org/10.3390/tomography7020013
AMA Style
Muzi M, O’Sullivan F, Perk TG, Muzi JP, Mankoff DA, Jeraj R, Duan F, Yu EY.
Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687. Tomography. 2021; 7(2):139-153.
https://doi.org/10.3390/tomography7020013
Chicago/Turabian Style
Muzi, Mark, Finbarr O’Sullivan, Timothy G. Perk, John P. Muzi, David A. Mankoff, Robert Jeraj, Fenghai Duan, and Evan Y. Yu.
2021. "Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687" Tomography 7, no. 2: 139-153.
https://doi.org/10.3390/tomography7020013
APA Style
Muzi, M., O’Sullivan, F., Perk, T. G., Muzi, J. P., Mankoff, D. A., Jeraj, R., Duan, F., & Yu, E. Y.
(2021). Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687. Tomography, 7(2), 139-153.
https://doi.org/10.3390/tomography7020013